Renal Transplantation in Primary Focal Segmental Glomerulosclerosis Using a Tolerance Induction Protocol

Transplantation Proceedings

Volumn 40, Issue 4, 2008, Pages 1108-1110

  Suthar, K ^a   Vanikar, A V ^a   Trivedi, H L ^b  

^a Transfusion Services and Immunohematology ^*  (India)

^b Research Centre   (India)

Author keywords

[No Author keywords available]

Indexed keywords

AZATHIOPRINE; AZORAN; CREATININE; CYCLOPHOSPHAMIDE; CYCLOSPORIN A; METHYLPREDNISOLONE; MYCOPHENOLIC ACID 2 MORPHOLINOETHYL ESTER; PREDNISOLONE; PREDNISONE;

ADOLESCENT; ADULT; AHMEDABAD TOLERANCE INDUCTION PROTOCOL; ARTICLE; CADAVER DONOR; CLINICAL ARTICLE; CLINICAL PROTOCOL; CONTROLLED STUDY; CREATININE BLOOD LEVEL; DEATH; DONOR SELECTION; FEMALE; FOCAL GLOMERULOSCLEROSIS; FOLLOW UP; GRAFT FAILURE; GROUPS BY AGE; HEMATOPOIETIC STEM CELL TRANSPLANTATION; HISTOLOGY; HLA MATCHING; HUMAN; IMMUNOLOGICAL TOLERANCE; IMMUNOSUPPRESSIVE TREATMENT; IRRADIATION; KIDNEY BIOPSY; KIDNEY GRAFT REJECTION; KIDNEY TRANSPLANTATION; LIVING DONOR; MALE; NONMYELOABLATIVE CONDITIONING; PRIORITY JOURNAL; PROTEINURIA; RECIPIENT; RENAL REPLACEMENT THERAPY;

ADOLESCENT; ADULT; CADAVER; CREATININE; FEMALE; GLOMERULOSCLEROSIS, FOCAL SEGMENTAL; HEMATOPOIETIC STEM CELL TRANSPLANTATION; HUMANS; IMMUNE TOLERANCE; KIDNEY TRANSPLANTATION; LIVING DONORS; MALE; MIDDLE AGED; POSTOPERATIVE COMPLICATIONS; RECURRENCE; RETROSPECTIVE STUDIES; TISSUE DONORS;

EID: 44949157207     PISSN: 00411345     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.transproceed.2008.03.076     Document Type: Article

References (8)

1. Holgado R., Castillo D.D., Mazuecos A., et al. Long term outcome of the focal segmental glomerulosclerosis after renal transplantation. Transplant Proc 31 (1999) 2304
2. Refaie A., Sobh M., Moustafa F., et al. Living-related donor kidney transplantation outcome in recipients with primary focal segmental glomerulosclerosis. Am J Nephrol 19 (1999) 55
3. Trivedi H.L., Shah V.R., Shah P.R., et al. Mega dose approach to PBSC infusion induced allograft hyporesponsiveness in living-related renal allograft recipients. Transplant Proc 33 (2001) 71
4. Trivedi H.L., Vanikar A.V., Shah V.R., et al. Mega dose unfractionated donor marrow derived cell infusion in thymus and periphery -An integrated clinical approach for tolerance in live related renal allograft. Transplant Proc 35 (2003) 203
5. Racusen L.C., Colvin R.B., Solez K., et al. Anti-body mediated rejection criteria: An addition to the Banff 97 classification of renal allograft rejection. Am J Transplant 3 (2003) 708
6. Kyu Hun C., Soon Il K., Soo Young Y., et al. Long-term outcome of kidney transplantation in adult recipients with focal segmental glomerulosclerosis. Yonsei Med J 42 (2001) 209
7. Ikehara S. Treatment of autoimmune diseases by hematopoietic stem cell transplantation. Exp Hematol 29 (2001) 661
8. Burt R.K., Slavin S., and Burns W.H. Induction of tolerance in autoimmune diseases by hematopoietic stem cell transplantation: getting closer to a cure?. Blood 99 (2002) 768